Insulin resistance (IR) caused by obesity-related inflammation was previously reported to be a risk factor for impaired pulmonary functions. Most studies addressed asthma or asthma-like symptoms, whereas very few addressed objective measures. We aimed to investigate the association between IR and pulmonary functions by evaluating FEV1, FVC, and FEV1/FVC in morbidly obese patients.
Materials and Methods:
Preanesthetic evaluation records of patients who underwent bariatric surgery were obtained. The presence of IR and metabolic syndrome (MetS) was analyzed for their correlations with the number of patients with FEV1, FVC, and FEV1/FVC measures lower than lower limit of normal (LLN). FEV1, FVC, and FEV1/FVC were analyzed as continuous variables for correlations with homeostasis model assessment of IR (HOMA-IR), body mass index (BMI), and fasting insulin.
Results:
There was no association between IR and FEV1, FVC, or FEV1/FVC. BMI, HOMA-IR scores, and fasting insulin levels were not correlated with FEV1/FVC. The number of patients whose FEV1, FVC, and FEV1/FVC were <LLN was similar in nondiabetic patients with or without IR and in patients with or without MetS. Despite statistical insignificance, the number of patients with FEV1<LLN was higher in patients with IR (p = 0.106).
Conclusions:
We found no association between IR and FEV1, FVC, or FEV1/FVC in morbidly obese patients.
Get full access to this article
View all access options for this article.
References
1.
SinghS, PrakashYS, LinnebergA, AgrawalA. Insulin and the lung: connecting asthma and metabolic syndrome. J Allergy, 2013; 2013:627384.
2.
DeFronzoRA, FerranniniE. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care, 1991; 14:173–194.
3.
EckelRH, GrundySM, ZimmetPZ. The metabolic syndrome. Lancet, 2005; 365:1415–1428.
4.
MaJ, XiaoL, KnowlesB. Obesity, insulin resistance and the prevalence of atopy and asthma in US adults. Allergy, 2010; 65:1455–1463.
5.
AssadN, QuallsC, SmithLJ, ArynchynA, ThyagarajanB, SchuylerM, et al.Body mass index is a stronger predictor than the metabolic syndrome for future asthma in women. The longitudinal CARDIA Study. Am J Respir Crit Care Med, 2013; 188:319–326.
6.
ThuesenBH, HusemoenLLN, HersougLG, PisingerC, LinnebergA. Insulin resistance as a predictor of incident asthma-like symptoms in adults. Clin Exp Allergy, 2009; 39:700–707.
7.
KozyrskiAL, ZengY, Saurek AleksandrovskaN, RamseyCD. Insulin resistance, puberty and non-atopic asthma in adolescent girls. Am J Resp Crit Care Med, 2014; 190:474–477.
8.
JimenezJS, EspinetFJH, GarridoJMM, AntonioJR, MayorSP, BoiraMMP, et al.Asthma and insülin resistance in obese children and adolescents. Pediatr Allergy Immunol, 2015; 25:699–705.
9.
HusemoenLLN, GlümerC, LauC, PisingerC, MorchLS, LinnebergA. Association of obesity and insulin resistance with asthma and aeroallergen sensitization. Allergy, 2008; 63:575–582.
10.
SagunG, GedikC, EkizE, KaragozE, TakirM, OguzA. The relation between insulin resistance and lung function: a cross-sectional study. BMC Pulm Med, 2015; 15:139.
11.
Serafino-AgrusaL, SpataforaM, ScichiloneN. Asthma and metabolic syndrome: current knowledge and perspectives. World J Clin Cases, 2015; 3:285–292.
HuisstedeA, CabezasMC, BirnieE, GeinjGJ, RudolphusA, MannaertsG, et al.Systemic inflammation and lung function impairment in morbidly obese subjects with the metabolic syndrome. J Obes, 2013; 2013:131349.
14.
SchumannR, ShikoraSA, SiglJC, KelleySD. Association of metabolic syndrome and surgical factors with pulmonary adverse events, and longitudinal mortality in bariatric surgery. Br J Anaesth, 2015; 114:83–90.
15.
NaveedB, WeidenMD, KwonS, GracelyEJ, ComfortAL, FerrierN, et al.Metabolic syndrome biomarkers predict lung function impairment: a nested case-control study. Am J Respir Crit Care Med, 2012; 185:392–399.
16.
LecubeA, SampolG, MunozX, LloberesP, HernandezC, SimoR. Insulin resistance is related to impaired lung function in morbidly obese women: a case-control study. Diabetes Metab Res Rev, 2010; 26:639–645.
17.
EckmannDM. In: MillerRonald D. (ed). Miller's Anesthesia eighth ed. 2015 Int ed. Anesthesia for Bariatric Surgery. Philadelphia, PA: Elsevier Saunders, 2015:2200–2216.
18.
TangQ, LiX, SongP, XuL. Optimal cut-off values for the homeostasis model assessment of insulin resistance (HOMA-IR) and pre-diabetes screening: developments in research and prospects for the future. Drug Discover Ther, 2015; 9:380–385.
19.
TopsakalS, YerlikayaE, AkınF, KaptanogluB, ErürkerT. Relation with HOMA-IR and thyroid hormones in obese Turkısh women with metabolic syndrome. Eat Weight Disord, 2012; 17:e57–e61.
20.
YılmazH, EvranM, SertM. Is it reliable to estimate insulin resistance by the methods of HOMA-IR or QUICKI in different disorders including type 2 diabetes mellitus, obesity, nonalcoholic fatty liver disease and chronic hepatitis C?. Acta Medica, 2015; 31:143.
21.
OymakY, UysalB, KarapinarTH, AyY, İnceD, DemiragB, et al.Obesity and insulin resistance after chemotherapy in patients with acute lymphoblastic leukemia. Blood, 2014; 124:5250.
22.
Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults. Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA, 2001; 285:2486–2497.
23.
BackmanH, LindbergA, SovijarviA, LarssonK, LundbackB, RönmarkE. Evaluation of the global lung function initiative 2012 reference values for spirometry in a Swedish population sample. BMC Pulm Med, 2015; 15:16.
QuanjerPH, BrazzaleDJ, BorosPW, PrettoJJ. Implications of adopting the global lungs initiative 2012 all-age reference equations for spirometry. Eur Respir J, 2013; 42:1042–1054.
26.
JohnsonJD, TheurerWM. A stepwise approach to the interpretation of pulmonary function tests. Am Fam Physician, 2014; 89:359–366.
27.
HuangH, GuoQ, LiL, LinS, LinY, GongX, et al.Effect of type 2 diabetes mellitus on pulmonary function. Exp Clin Endocrinol Diabetes, 2014; 122:322–326.
28.
HuY, MaZ, GuoZ, ZhaoF, WangY, CiL, et al.Type 1 diabetes mellitus is an independent risk factor for pulmonary fibrosis. Cell Biochem Biophys, 2014; 70:1385–1391.
29.
deFerrantiS, MozaffarianD. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem, 2008; 54:945–955.
30.
LeeEJ, InKH, HaES, LeeKJ, HurGY, KangEH, et al.Asthma-like symptoms are increased in the metabolic syndrome. J Asthma, 2009; 46:339–342.
31.
CaffarelliC, CalcinaiE, RinaldiL, DascolaCP, TerraccianoL, CorradiM. Hydrogen peroxide in exhaled breath condensate in asthmatic children during acute exacerbation and after treatment. Respiration, 2012; 84:291–298.
32.
CaffarelliC, DascolaCP, PeroniD, RicoS, StringariG, VariniM, et al.Airway acidification in childhood asthma exacerbations. Allergy Asthma Proc, 2014; 35:e51–e56.
33.
MinasM, KostikasK, PapaionnouAI, MystridouP, KaretsiE, GeorgouliasP, et al.The association of metabolic syndrome with adipose tissue hormones and insülin resistance in patients with COPD without co-morbidities. COPD, 2011:8:414–420.
